Cost-effectiveness of exemestane vs. tamoxifen in post-menopausal women with early breast cancer in Germany
Braun S, Mittendorf T, Greiner W, Dopatka J, von der Schulenburg JM (2007)
In: Value in Health. Value in Health, 10(6). Elsevier BV: A326.
Kurzbeitrag Konferenz / Poster
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Braun, S.;
Mittendorf, T.;
Greiner, WolfgangUniBi;
Dopatka, J.;
von der Schulenburg, J. M.
Einrichtung
Erscheinungsjahr
2007
Titel des Konferenzbandes
Value in Health
Serien- oder Zeitschriftentitel
Value in Health
Band
10
Ausgabe
6
Seite(n)
A326
ISSN
1098-3015
Page URI
https://pub.uni-bielefeld.de/record/1630675
Zitieren
Braun S, Mittendorf T, Greiner W, Dopatka J, von der Schulenburg JM. Cost-effectiveness of exemestane vs. tamoxifen in post-menopausal women with early breast cancer in Germany. In: Value in Health. Value in Health. Vol 10. Elsevier BV; 2007: A326.
Braun, S., Mittendorf, T., Greiner, W., Dopatka, J., & von der Schulenburg, J. M. (2007). Cost-effectiveness of exemestane vs. tamoxifen in post-menopausal women with early breast cancer in Germany. Value in Health, Value in Health, 10, A326. Elsevier BV. https://doi.org/10.1016/S1098-3015(10)65172-8
Braun, S., Mittendorf, T., Greiner, Wolfgang, Dopatka, J., and von der Schulenburg, J. M. 2007. “Cost-effectiveness of exemestane vs. tamoxifen in post-menopausal women with early breast cancer in Germany”. In Value in Health, 10:A326. Value in Health. Elsevier BV.
Braun, S., Mittendorf, T., Greiner, W., Dopatka, J., and von der Schulenburg, J. M. (2007). “Cost-effectiveness of exemestane vs. tamoxifen in post-menopausal women with early breast cancer in Germany” in Value in Health Value in Health, vol. 10, (Elsevier BV), A326.
Braun, S., et al., 2007. Cost-effectiveness of exemestane vs. tamoxifen in post-menopausal women with early breast cancer in Germany. In Value in Health. Value in Health. no.10 Elsevier BV, pp. A326.
S. Braun, et al., “Cost-effectiveness of exemestane vs. tamoxifen in post-menopausal women with early breast cancer in Germany”, Value in Health, Value in Health, vol. 10, Elsevier BV, 2007, pp.A326.
Braun, S., Mittendorf, T., Greiner, W., Dopatka, J., von der Schulenburg, J.M.: Cost-effectiveness of exemestane vs. tamoxifen in post-menopausal women with early breast cancer in Germany. Value in Health. Value in Health. 10, p. A326. Elsevier BV (2007).
Braun, S., Mittendorf, T., Greiner, Wolfgang, Dopatka, J., and von der Schulenburg, J. M. “Cost-effectiveness of exemestane vs. tamoxifen in post-menopausal women with early breast cancer in Germany”. Value in Health. Elsevier BV, 2007.Vol. 10. Value in Health. A326.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Suchen in
Google Scholar